483
Daniel H. Ahn D.O.FDA 483 - Daniel H. Ahn D.O. - September 22, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
During an inspection from September 18-22, 2023, the FDA issued a Form 483 to Daniel H. Ahn D.O., a clinical investigator in Phoenix, AZ. The inspection revealed a significant deviation from protocol, as the clinical investigation was not conducted in accordance with the signed statement of investigator and investigational plan. This included failures to complete required ECGs and Hematology/Chemistry labs for multiple subjects across various cycles.
Open in Dashboard
ID · e5af01fc-16e3-480e-8355-68777605efdf